Small Cap Stocks - Invest Million

Genprex Inc. (NASDAQ: GNPX) Up, As Independent Research Reveals TUSC2 Could Be A Therapy For Thyroid Cancer

Genprex Inc. (NASDAQ: GNPX) maintained upside momentum in yesterday’s session, and closed the day with gains of 23.44%. This came after news that, independent researchers had found the company’s TUSC2 to be a possible novel biomarker for treating thyroid cancer. The

Breaking News

Adaptimmune Therapeutics PLC (NASDAQ: ADAP) Up By 200% After Announcing Partnership Agreement With Astellas

Adaptimmune Therapeutics Plc (NASDAQ: ADAP) was one of the top gainers in yesterday’s trading session, and closed with gains of 200%. This came after the company announced that, it had entered into an agreement with Astellas for the development and commercialization of allogeneic

NASDAQ: TRIL

Trillium Therapeutics Inc (NASDAQ: TRIL) Rallies After Positive Data On TTI-621 Dosage

Trillium Therapeutics Inc (NASDAQ: TRIL) was a big gainer in yesterday’s trading session, and closed the day with gains of 93.96%. This came after the company announced progress on its TTI-621 and TTI-622 clinical programs. The CEO, Jan Skvarka announced that, the

NASDAQ: VSTM

Verastem Inc (NASDAQ: VSTM) Gains After Partnership With Chugai Pharma For The development Of CH5126766

Verastem Inc (NASDAQ: VSTM) was one of the top gainers in yesterday’s trading session. The followed an announcement that, the company had entered into a global licensing agreement with Chugai Pharmaceuticals CO. Ltd. Under the agreement, Verastem Inc. will get global development and

Investments

BioXcel Therapeutics Inc (NASDAQ: BTAI) Stock Technically Breaks Out After Initiating Trial For BXCL501

BioXcel Therapeutics Inc (NASDAQ: BTAI) made a new high in yesterday’s session, and closed the day with gains of 40.35%. This followed the company’s announcement that it had started its Sub-Lingual Dexmedetomidine in Agitation Associated with Schizophrenia and Bipolar disorder study

Financial

Small Cap Stock, Tetraphase Pharmaceuticals (NASDAQ: TTPH), Rallies After Earnings and Ratings

Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) was one of the top gainers in yesterday’s trading session. The stock rallied by 50% to close the day at $3.60. This followed a positive rating by 10 rating firms. Seven of them had a consensus of,

Breaking News

Microbot Medical (NASDAQ: MBOT) Soars After Announcing a Breakthrough in LIBERTY, a Technology For Remote Operations

Microbot Medical (NASDAQ: MBOT) was one of the top gainers just ahead of Christmas, and closed the day with gains of 61.03%. This followed the company’s announcement that, it was unveiling the world’s first disposable robotic system for cardiovascular, neurovascular and

NASDAQ: ONCY

Oncolytics Biotech (NASDAQ: ONCY) Sustains Gains Days After Positive News on Pelareorep, a Treatment For Solid Tumors

Oncolytics Biotech Inc (NASDAQ: ONCY) was a big gainer in Tuesday’s trading session, and closed the day with gains of 34.33%. This came a few days after the company announced acceptance of an abstract for a potential new biomarker data from the

NASDAQ Stocks

Adial Pharmaceuticals (NASDAQ: ADIL) Rallies After Validating Bio-marker For AD04 Phase 3 Trial

Adial Pharmaceuticals, Inc (NASDAQ: ADIL) was one of the top gainers at the close of the week after is gained by 30.95% in Friday’s session. This followed the company’s announcement that, it had validated its genetic biomarker for the planned phase

Financial

Technical Communications Corporation (NASDAQ: TCCO) Trades Heavy Volume After a Return to Profitability

Technical Communications Corporation (NASDAQ: TCCO) was one of the top gainers in Tuesday’s trading session. The stock gained by 308.16% to close the day at $8.00. This followed the company’s return to profitability after losses in the last financial year.